Britten Carolyn D相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials

免疫肿瘤临床试验中细胞因子释放综合征 (CRS) 的定义和报告需要统一

期刊:Cytotherapy

影响因子:3.2

doi:10.1016/j.jcyt.2022.01.004

Stewart, Mark D; McCall, Bruce; Pasquini, Marcelo; Yang, Allen S; Britten, Carolyn D; Chuk, Meredith; De Claro, R Angelo; George, Bindu; Gormley, Nicole; Horowitz, Mary M; Kowack, Eric; McCoy, Candice; Morrow, Phuong Khanh; Okoye, Emmanuel; Ricafort, Rosanna; Rossi, John; Sharon, Elad; Theoret, Marc; Vegni, Ferdinando; Yu, Tai; Allen, Jeff

细胞生物学

免疫/内分泌

发表日期：2022

文献求助收藏

Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in Oncology

肿瘤学中短暂性无症状转氨酶升高（TAEAT）的临床意义

期刊:American Journal of Clinical Oncology-Cancer Clinical Trials

影响因子:1.8

doi:10.1097/COC.0000000000000932

Lewis, James H; Khaldoyanidi, Sophia K; Britten, Carolyn D; Wei, Andrew H; Subklewe, Marion

发表日期：2022

文献求助收藏

Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma

一项针对人趋化因子（CC基序）受体2的小分子拮抗剂（PF-04136309）联合白蛋白结合型紫杉醇/吉西他滨一线治疗转移性胰腺导管腺癌的1b期研究

期刊:Investigational New Drugs

影响因子:2.7

doi:10.1007/s10637-019-00830-3

Noel, Marcus; O'Reilly, Eileen M; Wolpin, Brian M; Ryan, David P; Bullock, Andrea J; Britten, Carolyn D; Linehan, David C; Belt, Brian A; Gamelin, Eric C; Ganguly, Bishu; Yin, Donghua; Joh, Tenshang; Jacobs, Ira A; Taylor, Carrie T; Lowery, Maeve A

免疫/内分泌

发表日期：2020

文献求助收藏

Automatic trial eligibility surveillance based on unstructured clinical data

基于非结构化临床数据的自动试验资格监测

期刊:International Journal of Medical Informatics

影响因子:4.1

doi:10.1016/j.ijmedinf.2019.05.018

Meystre, Stéphane M; Heider, Paul M; Kim, Youngjun; Aruch, Daniel B; Britten, Carolyn D

发表日期：2019

文献求助收藏

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

阿维鲁单抗治疗铂类化疗失败后的转移性尿路上皮癌（JAVELIN 实体瘤）：一项开放标签 1 期试验的两个扩展队列的汇总结果

期刊:Lancet Oncology

影响因子:35.9

doi:10.1016/S1470-2045(17)30900-2

Patel, Manish R; Ellerton, John; Infante, Jeffrey R; Agrawal, Manish; Gordon, Michael; Aljumaily, Raid; Britten, Carolyn D; Dirix, Luc; Lee, Keun-Wook; Taylor, Mathew; Schöffski, Patrick; Wang, Ding; Ravaud, Alain; Gelb, Arnold B; Xiong, Junyuan; Rosen, Galit; Gulley, James L; Apolo, Andrea B

发表日期：2018

文献求助收藏

Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

BEZ235（一种双重PI3K/mTOR抑制剂）在晚期实体瘤患者（包括晚期乳腺癌患者）中的1/1b期剂量递增和扩展研究

期刊:Cancer Chemotherapy and Pharmacology

影响因子:2.3

doi:10.1007/s00280-018-3610-z

Rodon, Jordi; Pérez-Fidalgo, Alejandro; Krop, Ian E; Burris, Howard; Guerrero-Zotano, Angel; Britten, Carolyn D; Becerra, Carlos; Schellens, Jan; Richards, Donald A; Schuler, Martin; Abu-Khalaf, Maysa; Johnson, Faye M; Ranson, Malcolm; Edenfield, Jeff; Silva, Antonio P; Hackl, Wolfgang; Quadt, Cornelia; Demanse, David; Duval, Vincent; Baselga, Jose

发表日期：2018

文献求助收藏

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

Avelumab（一种抗程序性死亡配体1抗体）治疗难治性转移性尿路上皮癌患者：一项多中心Ib期研究的结果

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.2016.71.6795

Apolo, Andrea B; Infante, Jeffrey R; Balmanoukian, Ani; Patel, Manish R; Wang, Ding; Kelly, Karen; Mega, Anthony E; Britten, Carolyn D; Ravaud, Alain; Mita, Alain C; Safran, Howard; Stinchcombe, Thomas E; Srdanov, Marko; Gelb, Arnold B; Schlichting, Michael; Chin, Kevin; Gulley, James L

发表日期：2017

文献求助收藏

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors

ABC294640（一种首创的鞘氨醇激酶-2抑制剂）在晚期实体瘤患者中的I期研究

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-16-2363

Britten, Carolyn D; Garrett-Mayer, Elizabeth; Chin, Steven H; Shirai, Keisuke; Ogretmen, Besim; Bentz, Tricia A; Brisendine, Alan; Anderton, Kate; Cusack, Susan L; Maines, Lynn W; Zhuang, Yan; Smith, Charles D; Thomas, Melanie B

发表日期：2017

文献求助收藏

Racial Differences in Stage IV Colorectal Cancer Survival in Younger and Older Patients

种族差异对年轻和年长IV期结直肠癌患者生存率的影响

期刊:Clinical Colorectal Cancer

影响因子:3.2

doi:10.1016/j.clcc.2016.11.006

Wallace, Kristin; DeToma, Allan; Lewin, David N; Sun, Shaoli; Rockey, Don; Britten, Carolyn D; Wu, Jennifer D; Ba, Aissatou; Alberg, Anthony J; Hill, Elizabeth G

发表日期：2017

文献求助收藏

Phase Ib study of the mitochondrial inhibitor ME-344 plus topotecan in patients with previously treated, locally advanced or metastatic small cell lung, ovarian and cervical cancers

线粒体抑制剂 ME-344 联合拓扑替康治疗既往接受过治疗的局部晚期或转移性小细胞肺癌、卵巢癌和宫颈癌患者的 Ib 期研究

期刊:Investigational New Drugs

影响因子:2.7

doi:10.1007/s10637-017-0444-1

Diamond, Jennifer R; Goff, Barbara; Forster, Martin D; Bendell, Johanna C; Britten, Carolyn D; Gordon, Michael S; Gabra, Hani; Waterhouse, David M; Poole, Mark; Ross Camidge, D; Hamilton, Erika; Moore, Kathleen M

细胞生物学

发表日期：2017

文献求助收藏